-+ 0.00%
-+ 0.00%
-+ 0.00%

Windtree Therapeutics Q3 EPS $(1.08) Up From $(211.38) YoY

Benzinga·11/20/2025 00:23:15
Listen to the news
Windtree Therapeutics (OTC:WINT) reported quarterly losses of $(1.08) per share. This is a 99.49 percent increase over losses of $(211.38) per share from the same period last year.